Manteio Capital’s Vaxart VXRT Stock Holding History

Manteio Capital’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,378	Closed	-$90K	–	206
2021 Q4	$90K	Buy	+14,378	New	+$98.2K	0.12%	224

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Manteio Capital's VXRT Position: Q1 2022 in Review

Manteio Capital sold out of Vaxart (VXRT) in Q1 2022, closing a stake of 14,378 shares — an estimated $90K sold.

Manteio Capital first reported a position in VXRT in Q4 2021 and held it in 1 quarter. The position peaked at $90K in Q4 2021. 148 funds tracked by Wall St. Rank hold VXRT as of Q1 2022.

Manteio Capital reported no remaining Vaxart position as of Q1 2022 after selling out during the quarter.
Manteio Capital sold 14,378 Vaxart shares in Q1 2022, an estimated $90K.
Manteio Capital first reported a position in Vaxart in Q4 2021 and held it in 1 quarter.
Manteio Capital's Vaxart position peaked at $90K in Q4 2021.
148 funds tracked by Wall St. Rank held Vaxart as of Q1 2022.

Based on Manteio Capital's 13F filing for Q1 2022.